Medical Aesthetics Market: Information By Type (Surgical Procedures and Non-Surgical Procedures), End User and Regional Outlook — Forecast till 2026

Mar 29, 2019   Global Statistics Representing Medical Aesthetics Market Scenario Medical aesthetic procedures are performed to treat the skin and appearance conditions including wrinkles, crow’s feet, unwanted skin hairs, tattoo removal, and several others. Adoption rate of medical aesthetic procedures is high among adults and geriatric population. Availability of several options and surge in the number of skilled medical professionals offering non-surgical medical aesthetic procedures are the factors s...
TABLE OF CONTENT

Table Of Content

TABLE OF CONTENTS

1          Introduction

1.1       Market Definition

1.2       Market Scope

2          Research Methodology

2.1       Primary Research

2.2       Research Methodology

2.3       Assumptions & Exclusions

2.4       Secondary Data Sources

3          Market Overview

3.1       Report Segmentation & Scope

3.2       Value Chain Analysis: Medical Aesthetics Market

3.3       Key Market Trends

3.3.1    Drivers

3.3.2    Restraints

3.3.3    Opportunities

3.4       Porter’s Five Forces Analysis

3.4.1    Bargaining Power of Suppliers

3.4.2    Bargaining Power of Buyers

3.4.3    Threat of Substitution

3.4.4    Threat of New Entrants

3.4.5    Competitive Rivalry

3.5       Market Share Analysis

4          By Type Overview

4.1       Introduction

4.1.1    Market Size & Forecast (Value)

4.2       Surgical Procedures

4.2.1    Market Size & Forecast (Value)

4.3       Non-Surgical Procedures

4.3.1    Market Size & Forecast (Value)

5          By End User Overview

5.1       Introduction

5.1.1    Market Size & Forecast (Value)

5.2       Hospitals & Clinics

5.2.1    Market Size & Forecast (Value)

5.3       Cosmetic Procedural Centers

5.3.1    Market Size & Forecast (Value)

6          Regional Overview

6.1       Introduction

6.1.1    Market Size & Forecast (Value)

6.2       America

6.2.1    North America

6.2.1.1 U.S.

6.2.1.1.1          By Type

6.2.1.1.2          By End User

6.2.1.2 Canada

6.2.1.2.1          By Type

6.2.1.2.2          By End User

6.2.1.3 Mexico

6.2.1.3.1          By Type

6.2.1.3.2          By End User

6.2.1.4 Latin America

6.2.1.4.1          By Type

6.2.1.4.2          By End User

6.3       Europe

6.3.1    Market Size & Forecast (Value)

6.3.2    Germany

6.3.2.1          By Type

6.3.2.2          By End User

6.3.3    France

6.3.3.1          By Type

6.3.3.2          By End User

6.3. 4   U.K

6.3.4.1          By Type

6.3.4.2          By End User

6.3.5    Italy

6.3.5.1          By Type

6.3.5.2          By End User

6.3.6    Spain

6.3.6.1          By Type

6.3.6.2          By End User

6.3.7    Rest of Europe

6.3.7.1          By Type

6.3.7.2          By End User

6.4       Asia Pacific

6.4.1    Market Size & Forecast (Value)

6.4.2    Japan

6.4.2.1          By Type

6.4.2.2          By End User

6.4.3    China

6.4.3.1          By Type

6.4.3.2          By End User

6.4.4    Australia

6.4.4.1          By Type

6.4.4.2          By End User

6.4.5    India

6.4.5.1          By Type

6.4.5.2          By End User

6.4.6    South Korea

6.4.6.1          By Type

6.4.6.2          By End User

6.4.7    Rest of Asia-Pacific

6.4.7.1          By Type

6.4.7.2          By End User

6.5       Middle East & Africa

6.5.1    Market Size & Forecast (Value)

6.5.2    Saudi Arabia

6.5.2.1          By Type

6.5.2.2          By End User

6.5.3    South Africa

6.5.3.1          By Type

6.5.3.2          By End User

6.5.4    Kuwait

6.5.4.1          By Type

6.5.4.2          By End User

6.5.5    Rest of Middle East & Africa

6.5.5.1          By Type

6.5.5.2          By End User

7          Company Profile

7.1       Allergan

7.1.1    Company Overview

7.1.2    Financial Performance

7.1.3    Recent Developments

7.1.4    Product Portfolio

7.2       Alma Lasers, Ltd. (A Division of Sisram Medical Ltd.)

7.2.1    Company Overview

7.2.2    Financial Performance

7.2.3    Recent Developments

7.2.4    Product Portfolio

7.3       Anika Therapeutics, Inc.

7.3.1    Company Overview

7.3.2    Financial Performance

7.3.3    Recent Developments

7.3.4    Product Portfolio

7.4       Cutera, Inc.

7.4.1    Company Overview

7.4.2    Financial Performance

7.4.3    Recent Developments

7.4.4    Product Portfolio

7.5       Cynosure (A Wholly Owned Subsidiary of Hologic, Inc.)

7.5.1    Company Overview

7.5.2    Financial Performance

7.5.3    Recent Developments

7.5.4    Product Portfolio

7.6       El. En. S.P.A.

7.6.1    Company Overview

7.6.2    Financial Performance

7.6.3    Recent Developments

7.6.4    Product Portfolio

7.7       Fotona D.O.O.

7.7.1    Company Overview

7.7.2    Financial Performance

7.7.3    Recent Developments

7.7.4    Product Portfolio

7.8       Galderma (A Subsidiary of Nestlé))

7.8.1    Company Overview

7.8.2    Financial Performance

7.8.3    Recent Developments

7.8.4    Product Portfolio

            7.9       Johnson & Johnson

7.8.1    Company Overview

7.8.2    Financial Performance

7.8.3    Recent Developments

7.8.4    Product Portfolio